ASSOCIATION BETWEEN TUMOR HETEROGENEITY AND OVERALL SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

被引:7
|
作者
Song, Jiangdian [1 ,2 ]
Dong, Di [2 ]
Huang, Yanqi [3 ]
Liu, Zaiyi [3 ]
Tian, Jie [2 ]
机构
[1] Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Boston, MA 02115 USA
[2] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100864, Peoples R China
[3] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Guangdong, Peoples R China
来源
2016 IEEE 13TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI) | 2016年
关键词
Tumor heterogeneity; prognosis; non-small cell lung cancer; texture; radiomics; CT TEXTURE; NODULES;
D O I
10.1109/ISBI.2016.7493493
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this paper, a radiomics approach was proposed to determine whether the tumor heterogeneity of non-small cell lung cancer (NSCLC), which was measured by the texture on computed tomography (CT), could make an independent prediction of overall survival. A primary dataset contained 72 patients (mean survival, 15.9 months) with pathologic diagnosis of NSCLC and a validation dataset contained 67 NSCLC (mean survival, 18.1 months) patients which were used for prognosis trial. The experiment results indicated that the features: "energy of run-length (ERL)" (hazard ratio [HR]: 0.55, 95% confidence interval [CI]: (0.34, 0.89), P = 0.014) and "long-run high gray level emphasis of run-length (LRHGLERL)" (HR: 0.50, 95% CI: (0.32, 0.80), P = 0.005) were significantly associated with overall survival in the primary dataset, and these two texture features also make an consistent performance on the validation cohort. Our study further supported that the quantitative measurement of tumor heterogeneity can be associated with prognosis of NSCLC.
引用
收藏
页码:1249 / 1252
页数:4
相关论文
共 50 条
  • [1] Association Between Baseline Tumor Diameters and Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Gerber, D. E.
    Dahlberg, S. E.
    Sandler, A. B.
    Perry, M. C.
    Schiller, J. H.
    Brahmer, J. R.
    Johnson, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S217 - S218
  • [2] The association between body composition and overall survival in patients with advanced non-small cell lung cancer
    Fu, Liang
    Ding, Haiming
    Mo, Liupei
    Pan, Xiaoyu
    Feng, Lijuan
    Wen, Shenglian
    Lan, Qiaoqing
    Long, Liling
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [3] Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer
    Sun, Lova
    Bleiberg, Benjamin
    Hwang, Wei-Ting
    Marmarelis, Melina E.
    Langer, Corey J.
    Singh, Aditi
    Cohen, Roger B.
    Mamtani, Ronac
    Aggarwal, Charu
    JAMA ONCOLOGY, 2023, 9 (08) : 1075 - 1082
  • [4] Association between hospital volume and overall survival of patients with metastatic non-small cell lung cancer.
    Goyal, Gaurav
    Bartley, Adam C.
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Association between temporal muscle thickness and overall survival in non-small cell lung cancer patients with brain metastasis
    Yang, Seung Ho
    Kim, Young Il
    Kim, Hyun Ho
    Shim, Byoung Yong
    CANCER RESEARCH, 2023, 83 (02)
  • [6] Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis
    Kim, Young Il
    Shin, Ja Young
    Yang, Seung Ho
    Kim, Hyun Ho
    Shim, Byoung Yong
    Ahn, Stephen
    CURRENT ONCOLOGY, 2022, 29 (09) : 6463 - 6471
  • [7] Spirometry at diagnosis and overall survival in non-small cell lung cancer patients
    Zhai, Ting
    Li, Yi
    Brown, Robert
    Lanuti, Michael
    Gainor, Justin F.
    Christiani, David C.
    CANCER MEDICINE, 2022, 11 (24): : 4796 - 4805
  • [8] Relationship between age treatment and overall survival in patients with non-small cell lung cancer (NSCLC)
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Georgopoulou, A.
    LUNG CANCER, 2007, 55 : S10 - S10
  • [9] Association between baseline tumor dimensions and survival in advanced non-small cell lung cancer (NSCLC)
    Ahn, Daniel H.
    Dahlberg, Suzanne Eleanor
    Sandler, Alan
    Perry, Michael C.
    Schiller, Joan H.
    Brahmer, Julie R.
    Johnson, David H.
    Gerber, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Impact of tumor mutational burden on overall survival in patients with non-small cell lung cancer treated with immunotherapy
    Awad, Mark
    Mahadevan, Navin
    Polio, Andrew
    Vokes, Natalie
    Aguilar, Elizabeth
    Ricciuti, Biagio
    Lamberti, Giuseppe
    Recondo, Gonzalo
    Leonardi, Giulia
    Adeni, Anika
    Janne, Pasi
    Van Allen, Eliezer
    Albayrak, Adem
    Umeton, Renato
    Sholl, Lynette
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7